🔗 Permalink

Inventor profile of:

Daniel E. BAUER

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

15

Last publication date:

2025-05-15

Top Assignees for applications by Daniel E. BAUER

The entities that hold a legal rights for patent applications filed by inventor BAUER Daniel E.:

The Children's Medical Center Corporation 13 Boston, MA United States
THE BROAD INSTITUTE, INC. 3 Cambridge, MA United States
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 3 Cambridge, MA United States
UNIVERSITY OF MASSACHUSETTS 3 Boston, MA United States
Children"s Medical Center Corporation 2 Boston, MA United States
Dana-Farber Cancer Institute 1 Boston, MA United States

Recent patent applications by BAUER Daniel E.

Daniel E. BAUER from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-15

US20250154466A1

Chemistry; metallurgy

COMBINATION BCL11A ENHANCER EDITING

#2 | 2025-01-30

US20250034568A1

Chemistry; metallurgy

CONSTRUCTS COMPRISING TANDEM MICRORNA-ADAPTED SHORT HAIRPIN RNA (SHMIR) FOR INCREASING FETAL HEMOGLOBIN

#3 | 2024-07-25

US20240245725A1

Human necessities

METHODS FOR STRATIFYING SUBJECTS FOR FETAL HEMOGLOBIN REINDUCTION

#4 | 2023-11-02

US20230348887A1

Chemistry; metallurgy

TARGETING BCL11A DISTAL REGULATORY ELEMENTS FOR FETAL HEMOGLOBIN REINDUCTION

#5 | 2023-08-17

US20230257746A1

Chemistry; metallurgy

TARGETING ZNF410 FOR FETAL HEMOGLOBIN INDUCTION IN BETAHEMOGLOBINOPATHIES

#6 | 2023-07-27

US20230235285A1

Chemistry; metallurgy

TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION

#7 | 2022-12-01

US20220380757A1

Chemistry; metallurgy

BCL11A GUIDE AND BASE EDITOR DELIVERY

#8 | 2022-06-16

US20220186218A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR CORRECTED ABERRANT SPLICE SITES

#9 | 2021-04-22

US20210115420A1

Chemistry; metallurgy

ENHANCED BCL11A RNP / CRISPR DELIVERY & EDITING USING A 3XNLS-CAS9

#10 | 2021-02-18

US20210047632A1

Chemistry; metallurgy

Targeting BCL11A distal regulatory elements with a CAS9-CAS9 fusion for fetal hemoglobin reinduction

#11 | 2020-03-19

US20200087651A1

Chemistry; metallurgy

Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction

#12 | 2018-06-21

US20180171297A1

Chemistry; metallurgy

Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction

#13 | 2018-05-03

US20180119138A1

Chemistry; metallurgy

Functional genomics using CRISPR-Cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereof

#14 | 2018-05-03

US20180119130A1

Chemistry; metallurgy

Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction

#15 | 2015-10-29

US20150307867A1

Chemistry; metallurgy

Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction

InventorID:

1338495 ⎘